After 14 days of treatment, 64.6% of the patients taking ... More information: Jun Hamano et al, Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind ...

Background: Methylnaltrexone has been shown to be effective for treating opioid-induced constipation (OIC ... the use of methylnaltrexone for the treatment of OIC in patients with chronic ...

This pilot study suggests that methylnaltrexone actively induces laxation and is generally well tolerated in patients receiving mu-opioid analgesia, following orthopedic surgery, who develop OIC ...

Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: Results From an International Multicenter Study Preventive use of naldemedine for ...

Dulcolax and Colace can also be used for opioid-induced constipation (OIC ... what OTC options are best for your specific ...

Rizmoic is a once-daily 200-microgram oral tablet for the treatment of opioid induced constipation (OIC) in adult patients previously treated with a laxative. Shionogi received EU marketing ...

Stomachaches and pains can occur for various reasons, including constipation, gas, and heartburn. In some cases, ...

The deal is essentially a move to take control of Movantik (naloxegol), which is indicated for the treatment of one of the most prominent side effects of opioid analgesics – constipation – in ...

a mu-opioid receptor antagonist for the treatment of opioid induced constipation; Nouriast/ Nourianz, an adenosine receptor antagonist for Parkinson’s disease; and ORKEDIA, an oral calcimimetics ...